En español



Quick Links

OUD Phenotyping Feasibility for Clinical Trials (NIH HEAL Initiative)

Funded by the NIH HEAL Initiative

This study intends to develop a phenotypic characterization of a heterogenous sample of patients being treated for OUD, recruited from a variety of healthcare settings to obtain novel empirical data to improve our understanding of the clinical trajectories of individuals with OUD and offer predictions of illness severity and treatment retention and outcomes.  The study will also evaluate the feasibility of electronic, remote, phenotypic assessments that can be successfully embedded into imminent and future CTN/other OUD clinical trials.

CTN Protocol ID: 
Principal Investigator(s)
Kathleen Carroll, Ph.D.
VA Connecticut Healthcare Center (151D)
Department of Psychiatry
Yale University School of Medicine
950 Campbell Avenue
West Haven, CT 6516

Lisa A. Marsch, Ph.D.
Professor, Department of Psychiatry; Director, Center for Technology and Behavioral Health; Director, Dartmouth Psychiatric Research Center
Geisel School of Medicine at Dartmouth College
Department of Biomedical Data Science
46 Centerra Parkway, Suite 315
Lebanon, NH 03766

Get this Publication

    CTN Dissemination Initiative

    CTN Dissemination Initiative Logo

    Incorporates collaboration between clinicians, scientists, and experienced trainers.